SC 13G

Company

Vistagen Therapeutics, Inc.

Filed

September 18, 2020

Accession Number

0001019056-20-000505

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →